Religion and Vaccine Arguments

[tim]

The question the establishment then faced was direct. If cetuximab patients in Tennessee already carried anti-alpha-gal antibodies before treatment, what had sensitized them? The answer that mainstream allergy literature eventually settled on was the lone star tick. Within two years of the Chung paper, Scott Commins and Platts-Mills published a follow-up describing delayed anaphylaxis after red meat consumption in patients with the same specificity, and proposed tick bites as the originating exposure.⁹ The tick narrative had to be constructed because the establishment could not look at the alternative explanation. The alternative was that the southeastern US patients had received decades of injections containing mammalian proteins (gelatin, bovine serum albumin, mouse cell line residues) in vaccines and biologics, and had been sensitized by what Richet had explicitly described.

What Is Actually Being Injected

Gelatin appears as a stabilizer in at least eleven US vaccines, including MMR, MMRV, varicella, shingles, yellow fever, rabies, and Japanese encephalitis formulations.¹³ It is manufactured from collagen extracted from bovine hide and bones, porcine hide and bones, and occasionally tuna skin. Bovine serum albumin (BSA) is the blood protein from cattle used widely in the cell cultures that produce vaccines. It appears in the excipient lists for the inactivated polio vaccine (IPOL), Pentacel, Vaxelis, Quadracel, and others.¹⁴ Both gelatin and BSA carry alpha-gal residues. They are mammalian proteins delivered by injection into muscle, alongside aluminum adjuvant.

The Japanese medical literature contains the cleanest published case for the causal sequence. Between the late 1980s and the mid-1990s, the Japanese childhood schedule was restructured. The DTP whole-cell vaccine was replaced by an acellular version containing gelatin (DTaP). The age of administration was dropped from two years to three months. The new gelatin-containing DTaP was given before the live virus MMR, which also contained gelatin. Anaphylactic reactions to the MMR vaccine in Japanese children rose sharply, peaking in 1995 and 1996. Japanese investigators, in a series of peer-reviewed papers, concluded that the aluminum adjuvant in the DTaP had sensitized children to the trace gelatin proteins, and that subsequent exposure to gelatin in the MMR (or in food) triggered the anaphylactic response.¹⁵ Removal of gelatin from the DTaP was, in their words, “an ultimate solution for vaccine-related gelatin allergy.” New cases of gelatin allergy in Japanese children dropped after the formulation change.¹⁶

This is not a speculative reconstruction. It is the published, peer-reviewed conclusion of Japanese pediatric allergists working in the country’s own medical literature. They documented the schedule change, the rise in anaphylaxis, the mechanism, and the resolution after gelatin was removed. The Japanese literature is one of the rare admissions in mainstream science that vaccines cause food allergy through Richet’s mechanism, and the manufacturers did not contest it. The gelatin was removed from the Japanese DTaP, the cases dropped, and the matter was treated as resolved in Japan.

In the United States, gelatin was not removed from the affected vaccines. Children in the post-1989 cohort have continued to receive gelatin in MMR, MMRV, varicella, and other formulations across the expanded schedule, with bovine serum albumin in adjacent injections, and aluminum adjuvant in many of them. The schedule expansion that began in the late 1980s coincides almost exactly with the food allergy explosion that allergists describe as beginning around 1990.¹⁷ Vincent Pool and colleagues, in a 2002 Pediatrics paper, documented anti-gelatin antibodies in American children who had developed anaphylaxis after MMR vaccination.¹⁸ The mechanism was confirmed in the US population. Nothing was changed.

When American children develop delayed anaphylaxis after eating red meat in the 2010s and 2020s, the cohort effect is unmistakable. They were born into a schedule containing mammalian proteins. They have received injections of mammalian proteins. Their laboratory tests show what the establishment calls anti-mammalian IgE. They react to mammalian proteins. The mechanism is the one Richet documented in 1902 and the one the Japanese confirmed in the 1990s. The tick is the cover.

Alpha-gal is one instance of a wider pattern. Peanut allergy, which exploded in the same post-1989 cohort, follows the same mechanism. Peanut-oil excipients in pediatric injections and oral preparations, sensitized through aluminum-adjuvanted injection, then triggered on subsequent food exposure. Heather Fraser documents this in detail in The Peanut Allergy Epidemic.¹⁹ The proteins differ. The mechanism does not.

[tim]

What the Tick Story Cannot Explain

The Amish do not develop alpha-gal. They live in rural Pennsylvania, Ohio, Indiana, and elsewhere, surrounded by cattle and ticks. They are exposed to the lone star tick at rates the rest of the country could not match. They are also among the least-vaccinated populations in the United States. Researchers working with the Control Group Project, which followed more than 1,500 completely unvaccinated Americans across the age range out of a survey base of over 800,000, have noted that neither alpha-gal nor Lyme disease appears in the Amish or in the broader unvaccinated cohort at any meaningful rate.²²

This is the kind of natural experiment that mainstream epidemiology refuses to run. A population with maximum tick exposure, minimum vaccination exposure, and no detectable alpha-gal syndrome falsifies the tick hypothesis by itself. The standard allergist response, which is that the Amish must somehow be protected by their dairy diet or by some unspecified genetic factor or by reporting bias, is the same evasion that ran for decades around peanut allergy in non-Western populations. It is not a scientific reply. It is a holding pattern designed to avoid the structural conclusion the data is forcing.

The lone star tick has lived in the southeastern United States for centuries. Cattle have been there longer. Native Americans, early colonists, generations of farmers, and unvaccinated Amish communities have lived in proximity to both. No reliable population-level reports of meat allergy exist for any of them prior to the late twentieth century. The tick did not change. The schedule did. The cohort that develops alpha-gal is the cohort that has been injected with bovine proteins and aluminum adjuvant, a cohort that begins, with statistical clarity, around 1990.

A second falsification sits inside the establishment’s own laboratory work. No animal model of alpha-gal exists. No researcher has produced a carnivore that becomes allergic to meat after a tick bite. The molecular detection of alpha-gal in tick saliva, which the establishment cites as evidence of causation, is the same circular trick that virology uses to establish viruses. Find a molecule, assume a mechanism, declare the case closed. Detection is not causation. The amount of alpha-gal a tick could transfer in a single bite is orders of magnitude smaller than the amount delivered in a single vaccine dose, and the alpha-gal present in tick saliva most likely originates from the tick’s previous blood meal on a mammal in any case. The animal experiment that would settle the question has not been done, and is unlikely to be funded.

[tim]

[tim]

https://tdefender.substack.com/p/smoki ... uldnt-work

Smoking Gun? Documents Suggest Fauci Knew COVID Was Created in Wuhan Lab, and mRNA Vaccines Wouldn’t Work

In August 2021, Dr. Anthony Fauci received a U.S. intelligence report suggesting the COVID-19 virus was developed in Chinese and U.S. labs as a bat vaccine.

DARPA: Mass vaccination actually increased risks from SARS-CoV-2 virus

The virus also contained characteristics that made it difficult to treat or prevent with mRNA vaccines, the DARPA report suggested.

“The gene-encoded, or ‘mRNA,’ vaccines work poorly because they are synthetic replications of the already-synthetic SARSr-CoV-WIV spike proteins and possess no other epitopes” — or the part of an antigen that the immune system recognizes.

The report adds:

“The mRNA instructs the cells to produce synthetic copies of the SARSr-CoV-WIV synthetic spike protein directly into the bloodstream, wherein they spread and produce the same ACE2 immune storm that the recombinant vaccine does.

“Many doctors in the country have identified that the symptoms of vaccine reactions mirror the symptoms of the disease, which corroborates with the similar synthetic nature and function of the respective spike proteins.”

The DARPA report suggested that mass vaccination campaigns actually increased the risks from the SARS-CoV-2 virus, in a manner replicating that of gain-of-function research, which increases the virulence or transmissibility of viruses. It stated:

“The potential for SARSr-CoV-WIV to deattentuate requires immediate attention. Live vaccines have been found to deattentuate in the past.

“If this is the case with SARSr-CoV-WIV, then the mass vaccination campaign actually performs an accelerated gain-of-function for it. Since it is designed for bats off of a human-susceptible SARS-CoV, vaccinating humans against it actually gains its function back towards a more deattenuated human-susceptible form.”

For the same reasons, other pandemic-related interventions such as masks would be ineffective in stopping the spread of COVID-19, the report states.

“The reasons why nonpharmaceutical interventions like masks and medical countermeasures like the mRNA vaccines do not work well can be extrapolated from the details. Masks or mRNA vaccines would not work for this material,” said former pharmaceutical research and development executive Sasha Latypova. “It is a chemical aerosol poisoning agent. DARPA knows this well.”

Certain characteristics of SARS-CoV-2 made alternative treatment options, such as ivermectin, more effective in treating COVID-19, the report suggests.

“Many of the early treatment protocols ignored by the authorities work because they inhibit viral replication or modulate the immune response to the spike proteins.

“Some of these treatment protocols also inhibit the action of the engineered spike protein. For instance, Ivermectin (identified as curative in April 2020) works throughout all phases of illness because it both inhibits viral replication and modulates the immune response.

“Of note, chloroquine phosphate (Hydroxychloriquine, identified April 2020 as curative) is identified in the proposal as a SARSr-CoV inhibitor, as is interferon (identified May 2020 as curative).”